In the latest trading session, Boston Scientific (BSX) closed at $102.27, marking a +0.32% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.46%. On the ...

Boston Scientific (BSX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Boston Scientific (NYSE:BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own. BSX shares were trading +2.07% pre ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $102.32 which represents a slight increase of $0.05 or 0.05% from the prior close of $102.27. The stock opened at $102.28 and ...

Jan. 8, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...